NovaLipid’s strategic plan includes several key objectives:

• Continue to establish strategic alliances with leading pharmaceutical and biotechnology companies with animal health products in order to expand the development efforts of NovaLipids.

• Establish a diversified portfolio of products in a number of markets supported by key industry partners.

• Develop, through partnership and through the efforts of the Company, distribution and marketing programmes to promote and deliver NovaLipids branded products to niche markets that represent significant future opportunities.

• Maintain a cost structure that is competitive yet supports the research and development efforts required in maintaining a lead position.